Endothelin receptor antagonist CPU0213 suppresses ventricular fibrillation in L-thyroxin induced cardiomyopathy.

Journal Title: Pharmacological Reports - Year 2007, Vol 59, Issue 3

Abstract

Arrhythmias correlate with disorders of either K(2+) channels in sarcolemma or calcium modulating system in sarcoplasmic reticulum which handles Ca(2+) intracellularly. We hypothesized that an activated endothelin (ET) signaling pathway, which may be associated with an alteration of K(+) channels and Ca(2+) uptake activity in the myocardium, participated in the exaggerated ventricular fibrillation (VF) incidence in cardiomyopathy (CM) induced by L-thyroxin. We intended to test if a dual endothelin receptor antagonist CPU0213 is effective to suppress VF correlating with a reversal of abnormalities in expression of the ion channels in sarcolemma and sarcoplasmic reticulum. The CM was induced by L-thyroxin administration for 10 days, and the altered expression of ion channels and the ET system was examined and the susceptibility to VF was evaluated by 10-min ischemia followed by reperfusion (I/R). Rats were treated with either propranolol or CPU0213 from day 6-10 of L-thyroxin medication. An increased VF incidence on I/R episode in the CMwas found relative to control. An elevated myocardial ET-1 and preproET-1 expression were associated with abnormal mRNAlevel of sarcoplasmic/endoplasmic reticulum Ca(2+)-ATPase 2a (SERCA2a), phospholamban (PLB), and ERG, MinK, and Kv4.2 in sarcolemma. Propranolol and CPU0213 were equally effective in reversing the alterations of gene phenotype and exaggerated VF in CM hearts. In conclusion, an activated ET receptor signaling plays a role in the progression of augmented VF in association with abnormal expression of ion channels in both sarcolemma and sarcoplasmic reticulum in the CM.

Authors and Affiliations

Yu Feng, De-Zai Dai, Tao Na, Bing Cui, Yuan Zhang, Yin Dai

Keywords

Related Articles

Potential role of G protein-coupled receptor (GPCR) heterodimerization in neuropsychiatric disorders: a focus on depression.

G protein-coupled receptors (GPCRs) represent the largest family of membrane proteins in the human genome and are the target of approximately half of all therapeutic drugs. For many years, GPCRs were thought to exist and...

Effect of CYP2C9 and VKORC1 genetic variations on warfarin dose requirements in Indian patients.

Background: Warfarin, an oral anticoagulant is used in patients who are at increased risk of developing blood clots. The management of warfarin therapy is challenging because it shows large inter and intra individual var...

Red blood cells (RBCs), epoxyeicosatrienoic acids (EETs) and adenosine triphosphate (ATP).

In addition to serving as carriers of O(2), red blood cells (RBCs) regulate vascular resistance and the distribution of microvascular perfusion by liberating adenosine triphosphate (ATP) and epoxyeicosatrienoic acids (EE...

Large and micro coronary vascular involvement in diabetes.

Diabetes, with hyperglycemia as its hallmark, is a major risk factor forischemic heart disease. The role of coronary disease in the adverse prognosis of diabetes is controversial although the higher prevalence and extens...

Vane's blood-bathed organ technique adapted to examine the endothelial effects of cardiovascular drugs in vivo.

This study describes a modification of Vane's blood-bathed organ technique (BBOT). This new technique consisted of replacing the cascade of contractile smooth muscle organs within the traditional BBOT by a single collage...

Download PDF file
  • EP ID EP139218
  • DOI -
  • Views 100
  • Downloads 0

How To Cite

Yu Feng, De-Zai Dai, Tao Na, Bing Cui, Yuan Zhang, Yin Dai (2007). Endothelin receptor antagonist CPU0213 suppresses ventricular fibrillation in L-thyroxin induced cardiomyopathy.. Pharmacological Reports, 59(3), 306-314. https://europub.co.uk/articles/-A-139218